A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 25, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Metastatic Breast CancerHyperinsulinismHyperglycemia Drug Induced

Interventions

DRUG

Pioglitazone

hyperinsulinemia and hyperglycemia

Trial Locations (1)

RECRUITING

Rambam Health Care Campus, Haifa

All Listed Sponsors

lead

Rambam Health Care Campus

OTHER